Scandinavian Biopharma extends its agreement with USAMMDA and obtains additional financial support

In 2020, Scandinavian Biopharma entered into an agreement with the United States Army Medical Materiel Development Activity (USAMMDA) to fund manufacturing and development activities for its ETEC diarrhoea vaccine, ETVAX®. The agreement has now been extended, providing additional financial support. The objective of USAMMDA’s financial support is to accelerate the development and approval of the […]

Scandinavian Biopharma recruits Agneta Lissmats as Senior Director Biostatistics

Scandinavian Biopharma is now strengthening its organisation by recruiting Agneta Lissmats as Senior Director Biostatistics. The company is in late-stage clinical development and has an ambitious development program with several ongoing clinical studies for the ETEC vaccine candidate ETVAX®. Agneta has extensive experience in clinical drug development and has held similar positions at pharmaceutical companies […]